Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology ...
Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for craniofacial pain conditions, including migraine and trigem ...
Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for ...
Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI 100 (41.0%, 39.5%)Quality‑of‑life improvements and itch ...
Meningitis B latest: Cases linked to outbreak fall as infections downgraded but experts call for ‘vigilance’ - Experts warned ...
Visual Snow Syndrome (VSS) is a rare, chronic neurological condition characterized by a persistent, dynamic “TV-static” like ...
Sex differences in the prevalence, severity, and disability associated with pain are well documented in both clinical and preclinical research. Despite ...
Acquired hypothalamic obesity is typically precipitated by hypothalamic insult from tumors, treatment, trauma, stroke, or ...
Finding and eliminating the triggers for migraines can be helpful, but not everyone is able to identify their triggers.
Primary headache is common among US students, yet few seek medical care despite frequent medication use for migraine and ...